G. CENGİZ SEVAL Et Al. , "Clonal plasma cell detection by high sensitive flow cytometry in aphaeresis product is poor prognostic and not increased by use of plerixafor alone," 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , vol.54, Frankfurt, Germany, pp.496-497, 2019
CENGİZ SEVAL, G. Et Al. 2019. Clonal plasma cell detection by high sensitive flow cytometry in aphaeresis product is poor prognostic and not increased by use of plerixafor alone. 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , (Frankfurt, Germany), 496-497.
CENGİZ SEVAL, G., Uslu, A., DALVA, K., Bakanay, S. M., Merter, M., Sahin, U., ... İLHAN, O.(2019). Clonal plasma cell detection by high sensitive flow cytometry in aphaeresis product is poor prognostic and not increased by use of plerixafor alone . 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) (pp.496-497). Frankfurt, Germany
CENGİZ SEVAL, GÜLDANE Et Al. "Clonal plasma cell detection by high sensitive flow cytometry in aphaeresis product is poor prognostic and not increased by use of plerixafor alone," 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 2019
CENGİZ SEVAL, GÜLDANE C. Et Al. "Clonal plasma cell detection by high sensitive flow cytometry in aphaeresis product is poor prognostic and not increased by use of plerixafor alone." 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Frankfurt, Germany, pp.496-497, 2019
CENGİZ SEVAL, G. Et Al. (2019) . "Clonal plasma cell detection by high sensitive flow cytometry in aphaeresis product is poor prognostic and not increased by use of plerixafor alone." 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Frankfurt, Germany, pp.496-497.
@conferencepaper{conferencepaper, author={GÜLDANE CENGİZ SEVAL Et Al. }, title={Clonal plasma cell detection by high sensitive flow cytometry in aphaeresis product is poor prognostic and not increased by use of plerixafor alone}, congress name={45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)}, city={Frankfurt}, country={Germany}, year={2019}, pages={496-497} }